EP3386511
AÐFERÐIR TIL AÐ MEÐHÖNDLA HUNTINGTONS-SJÚKDÓM
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.12.2016EP published:
12.5.2021EP application number:
16874024.9
EP translation filed:
25.6.2021Grant published:
15.7.2021EPO information:
European Patent Register
Max expiry date:
10.12.2036Expiry date:
10.12.2024
Title:
METHODS FOR TREATING HUNTINGTON'S DISEASE
Timeline
Today
11.12.2016EP application
12.5.2021EP Publication
25.6.2021Translation submitted
15.7.2021Registration published
10.12.2024Expires
Owner
Name:
PTC Therapeutics, Inc.Address:
100 Corporate Court,, South Plainfield, NJ 07080, US
Inventor
Name:
BABU, SureshAddress:
Pennington, NJ 08534, US
Name:
BHATTACHARYYA, AnuradhaAddress:
Edison, NJ 08820, US
Name:
HWANG, SeongwooAddress:
Edison, NJ 08817, US
Name:
JANI, MinakshiAddress:
Iselin, NJ 08830, US
Name:
MOON, Young-choonAddress:
Belle Mead, NJ 08502, US
Name:
SYDORENKO, NadiyaAddress:
Princento, NJ 08540, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562265652 PDate:
10.12.2015Country:
US
Classification
Categories:
C07D 403/12, C07D 401/14, C07D 413/14, A61K 31/506, C07D 403/10, C07D 237/20, C07D 405/12, C07D 417/12, C07D 417/14, C07D 471/10, C07D 487/10, A61K 31/501, A61K 31/517
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 17.11.2021
Expires: 10.12.2022
Payer: Patice ehf.
Number: 7
Paid: 22.11.2022
Expires: 10.12.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.12.2023
Expires: 10.12.2024
Payer: Árnason Faktor ehf.